Clear Impact logo

End Hep C SF Data Dashboard - Program Performance Measures

P
Time Period
Current Actual Value
Current Trend
Why Is This Important?

Any person who has ever had HCV will produce a "reactive" result in an antibody test, including people with active HCV infections, people who cleared it on their own without treatment, and those who have been cured through treatment. If a client has a reactive HCV Antibody test they are then referred to confirmatory HCV RNA testing that will show whether they have an active infection that requires treatment or a former infection that doesn't require treatment. Once people get treated they are unable to spread the virus which helps us to turn the curve on the number of new HCV infections (incidence) as well the total number of HCV cases in San Francisco (prevalence). Increasing the number of antibody tests is one of End Hep C SF's primary goals because it means that we are testing more people who are at risk for HCV and linking more people to RNA testing and HCV treatment.

PM
Q4 2023
56
2
PM
Q4 2023
6.1%
1
P
Time Period
Current Actual Value
Current Trend
Why Is This Important?
P
Time Period
Current Actual Value
Current Trend
What We Do
Partners
P
Time Period
Current Actual Value
Current Trend
What We Do
Partners

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy